About: Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1993 (uk) article scientifique publié en 1993 (fr) im Mai 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1993 (ast) scientific article published on 01 May 1993 (en) գիտական հոդված հրատարակված 1993 թվականի մայիսի 1-ին (hy)
publication date	wds:Q72079776-9093BF9D-741E-449C-A69E-ACBB78A8EFED
publication date	1993-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q72079776-256EFFB0-14E0-420A-87E2-8FE9AA5F6A14 wds:Q72079776-37EED6B8-A33A-4903-A207-698A5469F32C wds:Q72079776-3B8E2E3D-31CD-4EFD-82B7-B10040BA5856 wds:Q72079776-4DA03105-A58C-4694-8A6F-9E0A00549C60 wds:Q72079776-6374211D-ADB2-4F51-A991-81910C3B7F0A wds:Q72079776-77AECAF0-431B-4A7D-803A-A7A67F64DCDD wds:Q72079776-9ACE83DB-43F9-49BA-9619-6B046C0DDDD1 wds:Q72079776-B2713BF3-3797-4E42-AD27-A84862C69241 wds:Q72079776-F0E312F1-23AD-4B20-B1CE-569FFE71928C wds:Q72079776-F794B265-9991-4A5E-9E97-F5B553D6D578
author name string	S B Cohen M L Lee P E Lipsky G W Cannon V Strand N J Olsen B Nelson L H Calabrese C Wiesenhutter T J Lorenz
rdfs:label	Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (en) Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (nl)
skos:prefLabel	Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (en) Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (nl)
name	Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (en) Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (nl)
title	wds:Q72079776-43C7141A-795E-41ED-BD1E-14E69E550E47
title	Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (en)
page(s)	wds:Q72079776-F7C79036-3690-4763-ADFD-AB31F22F59BC
page(s)	620-630
instance of	wds:Q72079776-EB6E6259-1EAC-4806-A4FF-0C8002EE808F
instance of	scholarly article
main subject	wds:Q72079776-3422297C-8592-4B5D-AFD3-665E9121CAC9
main subject	rheumatoid arthritis
PubMed ID	wds:Q72079776-EB4565B3-CAF8-4BE7-843D-0671611742FD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7683881
PubMed ID	7683881
published in	wds:Q72079776-65C2B754-8188-4ABD-8B5D-3D2F1A88FF54
published in	Arthritis and Rheumatism
issue	wds:Q72079776-872B524C-45B0-4771-A358-C6AF4237F751
volume	wds:Q72079776-1F328E0E-CFD6-4D3A-B670-B8081DAFE341
issue	5
volume	36
DOI	wds:Q72079776-323BC251-7EC4-4114-A862-A637DC1A81A5
DOI	http://dx.doi.org/10.1002/ART.1780360508
DOI	10.1002/ART.1780360508
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72079776
is cites work of	Toxin-based therapeutic approaches Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial. Biologic therapies in rheumatology: lessons learned, future directions Passive and active vaccination strategies to prevent ricin poisoning The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis Receptor-directed therapy of T-cell leukemias and lymphomas Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor. Ribosome-Inactivating Proteins from Plants: A Historical Overview Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis Immunological treatment of autoimmune diseases. Biologic agents for the treatment of rheumatoid arthritis Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets Streptococcal cell wall induced arthritis: leukocyte activation in extra-articular lymphoid tissue Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy Therapeutic potential of anti-HIV immunotoxins Anti-CD5 therapy decreases severity of established disease in collagen type II-induced arthritis in DBA/1 mice [Pathogenesis of rheumatoid arthritis] Innovative treatment approaches for rheumatoid arthritis. T-cell regulation Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates Biological therapies: a novel approach to the treatment of autoimmune disease Potential biologic agents for treating rheumatoid arthritis Ricin: An Ancient Story for a Timeless Plant Toxin Are immunoconjugates useful for therapy with autoimmune diseases? T cell-targeted immunofusion proteins from Escherichia coli B lymphocytes and humoral immune responses in rheumatoid arthritis Prospects of immunotherapy for rheumatoid arthritis Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials
is cites work of	wds:Q27013664-B1A8AF9D-55F6-4F4A-9268-8F0A132B1A33 wds:Q39227095-0AD602F4-8E23-4F91-973B-AFAE7C3D3AEA wds:Q73504871-11199895-6B48-4FD9-8992-C0A39CBE2F7A wds:Q89486119-CB8F8125-2043-4A29-8E1C-FC1A58170B36 wds:Q73697023-87341236-DF85-44D8-9431-26B0E8AB6586 wds:Q39229685-64034885-9246-4B0B-A5E6-7D539A3F4DA9 wds:Q38262399-F9E7253E-75C9-4457-8175-28FCEB187F9B wds:Q34276030-812D54F7-F548-4ED9-973B-5582C8F88911 wds:Q28078392-9F9A7BEE-52C6-4D44-9D27-0CEBCDB0762B wds:Q40968027-7393F9AE-3E24-45D5-9702-853277D88CC0 wds:Q40388190-D55C9578-473D-4FC9-A1EA-A2C52C5C9739 wds:Q37781913-E487D0DF-BFF6-40ED-9CA1-53A429C0A4FE wds:Q61863535-54A91746-6EAF-46CE-B0F9-DED9CAD1BEB7

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software